BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 26551415)

  • 1. Risk of secondary solid malignancies after allogeneic hematopoietic stem cell transplantation and preventive strategies.
    Adhikari J; Sharma P; Bhatt VR
    Future Oncol; 2015; 11(23):3175-85. PubMed ID: 26551415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuing increased risk of oral/esophageal cancer after allogeneic hematopoietic stem cell transplantation in adults in association with chronic graft-versus-host disease.
    Atsuta Y; Suzuki R; Yamashita T; Fukuda T; Miyamura K; Taniguchi S; Iida H; Uchida T; Ikegame K; Takahashi S; Kato K; Kawa K; Nagamura-Inoue T; Morishima Y; Sakamaki H; Kodera Y;
    Ann Oncol; 2014 Feb; 25(2):435-41. PubMed ID: 24399081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High incidence of oral squamous cell carcinoma independent of HPV infection after allogeneic hematopoietic SCT in Taiwan.
    Chen MH; Chang PM; Li WY; Hsiao LT; Hong YC; Liu CY; Gau JP; Liu JH; Chen PM; Chiou TJ; Tzeng CH
    Bone Marrow Transplant; 2011 Apr; 46(4):567-72. PubMed ID: 20622906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Second Malignancies after Hematopoietic Stem Cell Transplantation.
    Danylesko I; Shimoni A
    Curr Treat Options Oncol; 2018 Feb; 19(2):9. PubMed ID: 29423555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Total body irradiation is a crucial risk factor for developing secondary carcinomas after allogeneic hematopoietic stem cell transplantation in childhood.
    Keslova P; Formankova R; Riha P; Sramkova L; Snajderova M; Malinova B; Luks A; Sterba J; Stary J; Sedlacek P
    Neoplasma; 2020 Sep; 67(5):1164-1169. PubMed ID: 32657609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New malignant diseases after allogeneic marrow transplantation for childhood acute leukemia.
    Socié G; Curtis RE; Deeg HJ; Sobocinski KA; Filipovich AH; Travis LB; Sullivan KM; Rowlings PA; Kingma DW; Banks PM; Travis WD; Witherspoon RP; Sanders J; Jaffe ES; Horowitz MM
    J Clin Oncol; 2000 Jan; 18(2):348-57. PubMed ID: 10637249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral malignancies following HSCT: graft versus host disease and other risk factors.
    Demarosi F; Lodi G; Carrassi A; Soligo D; Sardella A
    Oral Oncol; 2005 Oct; 41(9):865-77. PubMed ID: 16084755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Second solid tumors: screening and management guidelines in long-term survivors after allogeneic stem cell transplantation.
    Socié G; Rizzo JD
    Semin Hematol; 2012 Jan; 49(1):4-9. PubMed ID: 22221779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk for secondary thyroid carcinoma after hematopoietic stem-cell transplantation: an EBMT Late Effects Working Party Study.
    Cohen A; Rovelli A; Merlo DF; van Lint MT; Lanino E; Bresters D; Ceppi M; Bocchini V; Tichelli A; Socié G
    J Clin Oncol; 2007 Jun; 25(17):2449-54. PubMed ID: 17557958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Second solid cancers after allogeneic hematopoietic stem cell transplantation.
    Gallagher G; Forrest DL
    Cancer; 2007 Jan; 109(1):84-92. PubMed ID: 17131350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secondary skin neoplasms in patients after autologous and allogeneic hematopoietic stem cell transplantation procedures.
    Szlauer-Stefańska A; Kamińska-Winciorek G; Giebel S; Bagłaj M
    Adv Clin Exp Med; 2020 Oct; 29(10):1221-1230. PubMed ID: 33064381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors Influencing Pulmonary Toxicity in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation in the Setting of Total Body Irradiation-Based Myeloablative Conditioning.
    Abugideiri M; Nanda RH; Butker C; Zhang C; Kim S; Chiang KY; Butker E; Khan MK; Haight AE; Chen Z; Esiashvili N
    Int J Radiat Oncol Biol Phys; 2016 Feb; 94(2):349-59. PubMed ID: 26853343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solid tumors after hematopoietic stem cell transplantation in Japan: incidence, risk factors and prognosis.
    Shimada K; Yokozawa T; Atsuta Y; Kohno A; Maruyama F; Yano K; Taji H; Kitaori K; Goto S; Iida H; Morishima Y; Kodera Y; Naoe T; Morishita Y
    Bone Marrow Transplant; 2005 Jul; 36(2):115-21. PubMed ID: 15908969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Academic difficulties and occupational outcomes of adult survivors of childhood leukemia who have undergone allogeneic hematopoietic stem cell transplantation and fractionated total body irradiation conditioning.
    Freycon F; Trombert-Paviot B; Casagranda L; Frappaz D; Mialou V; Armari-Alla C; Gomez F; Faure-Conter C; Plantaz D; Berger C;
    Pediatr Hematol Oncol; 2014 Apr; 31(3):225-36. PubMed ID: 24087985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Programmed death 1 ligand (PD-L1) in solid cancers after allogeneic hematopoietic stem cell transplantation: a retrospective analysis by the Nagasaki Transplant Group.
    Kasai S; Itonaga H; Niino D; Miyoshi H; Kato T; Imanishi D; Fujioka M; Furumoto T; Sato S; Sawayama Y; Taguchi J; Imaizumi Y; Hata T; Yoshida S; Moriuchi Y; Ohshima K; Miyazaki Y
    Int J Hematol; 2020 Oct; 112(4):524-534. PubMed ID: 32588395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solid cancers after bone marrow transplantation.
    Curtis RE; Rowlings PA; Deeg HJ; Shriner DA; Socíe G; Travis LB; Horowitz MM; Witherspoon RP; Hoover RN; Sobocinski KA; Fraumeni JF; Boice JD
    N Engl J Med; 1997 Mar; 336(13):897-904. PubMed ID: 9070469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health status, late effects and long-term survivorship of allogeneic bone marrow transplantation: a retrospective study.
    Gifford G; Sim J; Horne A; Ma D
    Intern Med J; 2014 Feb; 44(2):139-47. PubMed ID: 24320824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longterm followup and quality of life after hematopoietic stem cell transplantation.
    Sullivan KM
    J Rheumatol Suppl; 1997 May; 48():46-52. PubMed ID: 9150118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Old and new cancers after hematopoietic-cell transplantation.
    Majhail NS
    Hematology Am Soc Hematol Educ Program; 2008; ():142-9. PubMed ID: 19074072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.